Name
P02 -The Intersection of Chronic Pain and Addiction, Gregory Hobelmann, MD, MPH, 1.5 CE
Date & Time
Monday, June 25, 2018, 10:45 AM - 12:15 PM
Description
Gregory Hobelmann, MD, MPH
Patients with co-occurring chronic pain and substance use disorder are often difficult to treat. Each condition alone can affect individuals physically, emotionally, cognitively and spiritually, leading to decreased quality of life and often debilitation. Clinicians must understand the nature of both disorders and how they interact to best serve patients with comorbid disease. In this session, the presenter will review how neurobiology and the environment create susceptibility to addiction. In addition, we will discuss chronic pain and the devastating effects that it can cause in one’s life. We will then compare and contrast features of patients with each condition and discuss comprehensive, multimodality treatment that requires active patient participation.
Upon completion of this session, attendees will be able to:
* Gain an understanding of how neurobiology and environment create susceptibility to addiction.
* Review chronic pain and the nature of patients with chronic, debilitating pain conditions.
* Discuss comprehensive treatment for co-occurring pain and addiction.
Gregory Hobelmann, MD, MPH
Gregory Hobelmann started as a staff psychiatrist at Ashley Addiction Treatment in 2017 after completing his psychiatry residency at Johns Hopkins. He also completed an anesthesiology residency and pain medicine fellowship at Johns Hopkins in 2006. Prior to his psychiatry residency, he worked at Ashley for a year as a staff physician and was in an interventional pain medicine practice for three years. He received a bachelor’s degree in biology from Georgetown University and a master of public health from Johns Hopkins. His interests are in addiction and treating patients with chronic debilitating pain.
Patients with co-occurring chronic pain and substance use disorder are often difficult to treat. Each condition alone can affect individuals physically, emotionally, cognitively and spiritually, leading to decreased quality of life and often debilitation. Clinicians must understand the nature of both disorders and how they interact to best serve patients with comorbid disease. In this session, the presenter will review how neurobiology and the environment create susceptibility to addiction. In addition, we will discuss chronic pain and the devastating effects that it can cause in one’s life. We will then compare and contrast features of patients with each condition and discuss comprehensive, multimodality treatment that requires active patient participation.
Upon completion of this session, attendees will be able to:
* Gain an understanding of how neurobiology and environment create susceptibility to addiction.
* Review chronic pain and the nature of patients with chronic, debilitating pain conditions.
* Discuss comprehensive treatment for co-occurring pain and addiction.
Gregory Hobelmann, MD, MPH
Gregory Hobelmann started as a staff psychiatrist at Ashley Addiction Treatment in 2017 after completing his psychiatry residency at Johns Hopkins. He also completed an anesthesiology residency and pain medicine fellowship at Johns Hopkins in 2006. Prior to his psychiatry residency, he worked at Ashley for a year as a staff physician and was in an interventional pain medicine practice for three years. He received a bachelor’s degree in biology from Georgetown University and a master of public health from Johns Hopkins. His interests are in addiction and treating patients with chronic debilitating pain.